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ABSTRACT
Increased activity of the mRNA helicase eIF4A
drives cellular malignancy by reprogramming cel-
lular translation, and eIF4A activity is the direct
or indirect target of many emerging cancer thera-
peutics. The enriched presence of (GGC)4 motifs,
which have the potential to fold into two-layered G-
quadruplexes, within the 5′UTRs of eIF4A-dependent
mRNAs suggests that eIF4A is required for the
unwinding of these structures within these eIF4A-
controlled mRNAs. However, the existence of folded
G-quadruplexes within cells remains controversial,
and G-quadruplex folding is in direct competition
with classical Watson–Crick based secondary struc-
tures. Using a combination of reverse transcrip-
tion stalling assays and 7-deazaguanine incorpora-
tion experiments we find that (GGC)4 motifs prefer-
entially form classical secondary structures rather
than G-quadruplexes in full-length mRNAs. Further-
more, using translation assays with the eIF4A in-
hibitor hippuristanol, both in vitro and in cells,
we find that eIF4A activity alleviates translational
repression of mRNAs with 5′UTR classical sec-
ondary structures significantly more than those with
folded G-quadruplexes. This was particularly evi-
dent in experiments using a G-quadruplex stabi-
lizing ligand, where shifting the structural equilib-
rium in favour of G-quadruplex formation diminishes
eIF4A-dependency. This suggests that enrichment of
(GGC)4 motifs in the 5′UTRs of eIF4A-dependent mR-
NAs is due to the formation of stable hairpin struc-
tures rather than G-quadruplexes.
INTRODUCTION
Regulation of translation plays a major role in determin-
ing the final levels of proteins within the cell (1), and is
finely controlled to ensure accurate composition of the pro-
teome (2). In general, most regulation occurs at transla-
tion initiation, during which the eukaryotic initiation fac-
tor (eIF) complex eIF4F recruits the small ribosomal sub-
unit to the 5′ end of the mRNA. This step is dependent
on unwinding of secondary structures by eIF4F’s effector
subunit, the DEAD box RNA helicase eIF4A (3,4). The
eIF4F complex is situated at the nexus of many mitogenic
signalling pathways (5,6), where it exerts pervasive control
over mRNA translation. These pathways are often hyper-
activated in cancer cells, ensuring enhanced levels of trans-
lation, which is essential for their continued growth and sur-
vival (5–8). Increased eIF4A activity is a common feature
of malignancy (9), often leading to drug resistance (10–12),
and has become an attractive target for cancer therapeutics,
with eIF4A-specific inhibitors showing very promising anti-
neoplastic results in mouse models of the disease (13–15).
To gain an in-depth mechanistic understanding of why
eIF4F activity is critical for driving malignancy, several
groups, including our own, have carried out either polysome
profiling or ribosome footprinting after eIF4A inhibition
(9,13,16). Crucially, all three studies showed that the re-
quirement for eIF4A activity was not equal among all mR-
NAs and that those mRNAs most dependent on eIF4A
for their translation were enriched for transcripts encod-
ing a range of oncogenic proteins such as CDC25B, c-MYC
and cyclin D1 (9,13,16). These eIF4A-dependent mRNAs
also had longer 5′UTRs, with increased propensity for sec-
ondary structures, suggesting a model in which cancer cells
require higher levels of eIF4A activity in order to acquire
an oncogenic translational program. Interestingly, two of
these studies also reported that these 5′UTRs were enriched
with a (GGC)4 motif, that has the potential to fold into aG-
quadruplex (9,13). This has been widely interpreted as evi-
dence that these tertiary structures add an additional layer
of regulation by conferring increased dependency on eIF4A
activity to those mRNAs that possess potential quadruplex
forming sequences within their 5′UTRs.
G-quadruplexes are stable structures formed from stacks
of two or more G-tetrads (17). Each G-tetrad is composed
of four guanine residues, where each guanine is bound to
two others throughHoogsteen interactions. They have been
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implicated in many aspects of RNA biology (18,19), in-
cluding translation, where stable G-quadruplexes have been
shown to inhibit cap-dependent translation (20–23). How-
ever, although it is accepted that they form in in vitro assays,
whether or not they really fold in cells remains controver-
sial (24), with evidence both in support (25–27) and against
(28). Although bioinformatic searches for potential quadru-
plex sequences (PQSs) show these PQSs to be enriched in
UTR regions (29), including the 5′UTRs of known onco-
genic mRNAs (30) such as BCL2 (31,32) and NRAS (33),
it is clear that the presence of the sequence alone does not
mean the G-quadruplex will be folded within a full length
mRNA (24). Also, these searches historically looked for
PQSs which would possess three G-tetrads and a loop of
seven nucleotides or less, whereas it is now clear that G-
quadruplexes can form in vitro with just two layers of G-
tetrads, with large internal loops, and with bulges within the
G-tracts (24,34–39). The (GGC)4 motif that we and oth-
ers see enriched in the 5′UTRs of eIF4A dependent mR-
NAs would fold into a G-quadruplex with just two layers of
G-tetrads. Although biophysical techniques such as circu-
lar dichroism (CD) and ultraviolet (UV) melting curves are
commonly used to demonstrate quadruplex folding for cer-
tain sequences, these techniques use short oligonucleotides,
and cannot distinguish between inter-molecular and intra-
molecular G-quadruplexes (24). Furthermore in full-length
mRNAs, G-quadruplex formation is in direct competition
with alternative secondary structures, notably with classical
Watson–Crick base-paired helices (24). Biophysical tech-
niques alone, therefore, cannot be relied upon to prove that
a G-quadruplex is able to form in full length mRNAs.
To fully understand the biological implications of eIF4A
inhibition, or the potential value of directly targeting G-
quadruplexes, we must determine the extent, if any, by
which G-quadruplexes confer increased dependency on
eIF4A activity for translation. To this end we have car-
ried out translation assays for a wide range of reporter
constructs with different G-quadruplex forming sequences,
both in vitro and in cells with and without the eIF4A-
specific small molecule inhibitor hippuristanol (40). In par-
allel, we used reverse transcription stalling assays (41) to
detect quadruplex folding in full length mRNA, and fur-
ther tested the effects of G-quadruplex folding modulations
by the use of synthetic nucleotides in cis, and quadruplex-
binding small molecules in trans.
MATERIALS AND METHODS
Cell culture
MCF7 cells were cultured in DMEM (ThermoFisher
41966) with 10% FCS. Cells were tested regularly for my-
coplasma and were authenticated by Eurofins using PCR-
single-locus-technology.
Cloning
Annealed oligos were cloned into the pGL3-promoter plas-
mid (Promega E1761) between the HindIII and NcoI re-
striction sites directly upstream of the Fluc open reading
frame. CDC25B, GNAS and GNA11 were cloned by Gen-
Script due to their length and high GC content. 5′UTR
sequences, directly downstream of the SV40 promotor are
shown in Supplementary Table S1. All constructs were ver-
ified with bi-directional Sanger sequencing.
PCR
Template DNA for the in vitro transcription reactions was
synthesized using PCR from the plasmids used for DNA
transfections, in order to incorporate the T7 binding site
and (A)25 tail. HCV-pRL template was synthesized from
the HCV-pRL plasmid, kindly donated byMartin Bushell’s
lab. Primer sequences are shown in Supplementary Table
S2. Q5 High Fidelity DNA Polymerase (M0491S) was used
as per manufacturer’s instructions with the addition of 1X
Q5 High GC Enhancer.
In vitro transcription
mRNAs used in Figures 1, 3–5 and Supplementary Figure
S3 were transcribed using the mMessage mMachine Ultra
kit (ThermoFisher AM1345) as per manufacturer’s instruc-
tions. This kit uses the anti-reverse cap analogue (ARCA) to
ensure the cap is in the correct orientation. mRNA was pu-
rified using the MEGAclear kit (ThermoFisher AM1908)
and quantified by nanodrop. Integrity of RNAwas checked
by inspection on a native agarose gel.
mRNAs used in Supplementary Figure S1 and Figure
2 were transcribed using the TranscriptAid T7 High Yield
Transcription Kit (ThermoFisher K0441) as per manufac-
turer’s instructions. For Supplementary Figure S1, 7.5 mM
ATP/CTP/UTP, 1.5 mM GTP and either 6 mM ARCA
(NEB S1411S) or 6 mM G(5′)ppp(5′)A RNA Cap Struc-
ture Analog (NEB S1406S) was used whereas for Figure 2,
7.5 mMATP/CTP/UTP, 6mMARCA (S1411S) and either
1.5 mMGTP or 1.5 mM 7-deazaguanine (TriLink N-1044)
was used.
HCV-Rluc RNA was transcribed with the MEGAscript
kit (ThermoFisher AM1333) and was not capped.
RNA for reverse transcription stalling experiments was
transcribed using the MEGAscript kit. This RNA was the
same as that mRNA used in translation assays, except with-
out a 5′ cap.
In vitro translation assays
Cell free extracts were derived from MCF7 cells following
the protocol described in (42). Large volumes of cells were
grown to 70–80% confluency using Nunc EasyFill Cell Fac-
tories. Cells were collected using trypsin, followed by de-
activation with twice the volume of media with 10% FCS
and washed twice with room temp PBS. The cell pellet was
then resuspended with an equal volume of ice cold hypo-
tonic buffer (10 mMHepes pH 7.5, 10 mMKOAc, 0.5 mM
MgOAc, 5 mMDTT, 1× EDTA free proteinase inhibitors)
and left to swell on ice for 1 h (cells were kept in solution
with gentle flicking every 10 min). Cells were homogenized
by forcing through a 27G needle using a 1 ml syringe 15
times and centrifuged at 12 000g in a micro centrifuge for
5 min at 4◦C. Supernatant was aliquoted and stored at -
80◦C. Protein concentration was measured using Bradford
reagent. Each biological replicate used a different batch of
extracts using cells grown and lysed on different days.
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in vitro translation assays were carried out with 120 fmol
Fluc reporter mRNA (150ng) and 120 fmol HCV-Rluc
RNA (50 ng) in 15 l reactions for 1 h at 37◦C. Each re-
action contained 100 g cell free extract (5 l), 15 mM
Hepes (pH 7.5), 25 g/ml creatine phosphokinase, 7.5 mM
creatine phosphate, 0.1 mM spermidine, 75 mM KOAc,
0.75 mM MgOAc, 20 U RNasein Ribonuclease Inhibitor
(Promega N2111) and the relevant concentration of either
hippuristanol (kind gift from Junichi Tanaka), pyridostatin
(Cambridge Bioscience) or an equal volume of DMSO. All
of the above ingredients were first titrated so that the re-
action was optimal; in our hands adding exogenous amino
acids was not necessary. After the reactions had finished
they were placed on ice and Fluc and Rluc measurements
were obtained using the Dual-Luciferase Reporter Assay
System (Promega E1980) and the GloMax-96 Microplate
Luminometer. 25 l of both the LAR II and Stop & Glo
reagent were added to 5 l of each in vitro translation reac-
tion in duplicate. Biological replicates were carried out on
different days.
Cellular translation assays
0.5 × 105 MCF7 cells were seeded per well in 24-well plates
16 h prior to transfection with 450 ng pGL3-promotor plas-
mid (with the relevant 5′UTR sequence cloned upstream
of the Fluc ORF) and 50ng pRL Renilla Luciferase Con-
trol SV40 plasmid (Promega E2231), using 1.5 l Lipofec-
tamine 2000 transfection reagent (ThermoFisher 11668019)
in duplicate. Eight hours afterwards, media was replaced
with fresh media containing hippuristanol (kind gift from
Junichi Tanaka), silvestrol (MedChem Express HY-13251),
pyridostatin (Cambridge Bioscience) or DMSO. Cells were
lysed 16 h later with 100 l passive lysis buffer and Fluc
and Rluc measurements were obtained using the Dual-
Luciferase Reporter Assay System (Promega E1980) and
the GloMax-96 Microplate Luminometer. Twenty five mi-
crolitre of both the LAR II and Stop & Glo reagent were
added to 5 l of lysate in duplicate. Biological replicates
were carried out on different days.
Normalizing Fluc and Rluc measurements
in vitro translation assays were normalized to HCV-Rluc.
The translation of Rluc was eIF4A-independent, as it is
under the control of the HCV internal ribosome entry site
(IRES). Levels of Rluc increased with increasing concentra-
tions of hippuristanol, most likely due to the competition
with cellular mRNAs, as these extracts were not nuclease
treated. In cells however, transfection with the HCV-pRL
plasmid produced Rluc which was very sensitive to hip-
puristanol, presumably as the mRNA will be transcribed in
the nucleus and will therefore be capped. We therefore used
the pRL Renilla Luciferase Control SV40 plasmid, which
produces Rluc with a 5′UTR of moderate length and struc-
ture, to normalize against in cells. This was also sensitive
to hippuristanol but less so than the HCV-Ren plasmid.
HCV-Rluc and Rluc measurements were first adjusted by
normalizing to the average change with hippuristanol, sil-
vestrol or pyridostatin (or both hippuristanol and pyrido-
statin) within each biological replicate. For example, if hip-
puristanol caused Rluc measurements to decrease by 50%
on average, each individual Rluc measurement with hip-
puristanol was divided by 0.5. This means that the average
Rluc measurement for all reporters was the same between
each treatment (with or without drug). Fluc measurements
were then normalized to these adjustedRlucmeasurements.
Individual Fluc and Rluc levels are plotted for each experi-
ment in Supplementary Figures S7–13.
Reverse transcription stalling
Reverse transcription stalling assays were essentially carried
out as in (41). 2.5 pmol RNA was mixed with 5 pmol 5′
Cy5 labelled Luc RT primer (Supplementary Table S2) in
10 mM Tris–HCl (pH 7.5) and 75 mM KCl/LiCl in 5 l.
This was heated at 95◦C in a thermal cycler for 1 min be-
fore cooling to 35◦C. 2 l 5× buffer (100 mM Tris–HCl
(pH 8.4), 187.5 mM KCl/LiCl, 2.5 mM dNTPs, 20 mM
MgCl2 and 5 mM DTT) was added along with the rel-
evant concentration of pyridostatin/DMSO and nuclease
free water to take the reaction to 9.5 l. The reaction was
incubated at 35◦C for 5 min, before the temperature was
increased to 55◦C where the reaction was incubated for
21 min, with 0.5 l SuperScript III reverse transcriptase
(200 U/l) (ThermoFisher 18080044) being added after
1 min. 1l NaOH (1M) was then added to the reaction and
incubated at 95◦C to degrade the RNA. Samples were then
mixed with an equal volume of 2× loading buffer (95% for-
mamide, 20 mM Tris–HCl (pH 8), 20 mM EDTA, 0.025%
bromophenol blue), heated at 95◦C for 3 min and 3.5 l
was loaded onto a pre-run 6% denaturing polyacrylamide
sequencing gel. Gel was run at 45 W for 1.5 h which kept
the temperature at 50◦C and the gel was imaged using a Ty-
phoonFLA9000. Ladder sequenceswere run alongside and
were made exactly as above, except adding 2 mM ddCTP to
the reaction (4:1 ratio over dCTP)
RNA structure predictions
Predicted RNA structure and minimum free energy was
calculated using RNAfold (43). GQRS mapper was used
to confirm the presence/absence of overlapping/non-
overlapping potential G-quadruplex sequences within our
reporter constructs (44).
RESULTS
Experimental design
To test whether eIF4A is required to unwind G-
quadruplexes within 5′UTRs during translation initiation,
we designed reporter constructs with either four (GGC)4
motifs or four (GGGC)4 motifs within the 5′UTRs of
firefly luciferase (FLuc) constructs (Figure 1A). These
motifs have the potential to form either two-layered
(GQ2) or three-layered (GQ3) G-quadruplexes. These
reporters were used in translation assays with and without
the eIF4A-specific inhibitor hippuristanol, both in vitro
and in cells. In vitro assays utilized an MCF7 derived
cell-free translation system, as in (42), that reconstitutes
the synergism between the 5′ cap and the poly(A) tail, and
in which hippuristanol inhibits translation of capped but
not A-capped mRNAs (Supplementary Figure S1). The in
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Figure 1. Three-layered but not two-layered G-quadruplexes cause eIF4A dependency. (A) Diagrammatic representation of the reporter constructs used in
this figure. (B) Reverse transcription stalling assays using full length RNA shows K+ dependent stalling (red star) one nucleotide before the G-quadruplex
sequences (blue lines) in GQ3 but not GQ2 or either control. G-ladders were obtained from GQ2/3 RNA with Li+ and the addition of ddCTP. (C) in vitro
translation assays with and without 4 M hippuristanol. Fluc was normalized to HCV-Rluc (right axis) and then normalized to 0 M hippuristanol (left
axis). n = 4 biological replicates. (D and E) Cellular translation assays with and without either 200 nM hippuristanol (D) or 5 nM silvestrol (E). Fluc was
normalized to Rluc (right axis) and then normalized to 0 nM hippuristanol/silvestrol (left axis). n = 3 biological replicates. Error bars represent SEM. ns
= not significant, **P < 0.01 and ****P < 0.0001 using a repeated measures one-way ANOVA with Sidak’s multiple comparisons test. Individual Fluc
and Rluc measurements are presented in Supplementary Figure S7.
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Figure 2. 7-deazaguanine de-represses GQ3 translation and eIF4A dependency. (A) Structure of guanine with the N7 position circled in red and 7-
deazaguanine with the C7 position circled in red. (B) Structure of a Watson Crick G:C base pair. The N7 position of guanine is circled in red. Hydrogen
bonds are shown with dotted lines. (C) Structure of a G-tetrad, where each guanine is bound to two additional guanines through Hoogsteen base pairing.
The N7 position of guanine is circled in red. (D) Reverse transcription stalling assay shows that GQ3RNA transcribed with 7-deazaguanine (c7G) is unable
to fold into G-quadruplexes, as evident from the absence of K+ dependent stalling (red star) observed for GQ3. Each G-ladder was obtained from each
RNAwith Li+ and the addition of ddCTP, demonstrating that the RNA sequence is the same. (E and F) in vitro translation assays with mRNA transcribed
with 7-deazaguanine instead of guanine. For E, Fluc was normalized to HCV-Rluc (right axis) and then normalized to Fluc/HCV-Rluc values for the
corresponding reporter transcribed with normal guanine (left axis). For F, each reporter was normalized to 0 M hippuristanol. c7G represents RNAs
transcribed with 7-deazaguanine. n= 3 biological replicates. Error bars represent SEM. ns= not significant and ****P< 0.0001 using a repeated measures
two-way ANOVA with Sidak’s multiple comparisons test. Individual Fluc and Rluc measurements are presented in Supplementary Figure S8.
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vitro translation assays have the advantage of a precisely
known and quantified mRNA transcript, but otherwise
relatively artificial conditions. By contrast, the cellular
assays were performed by DNA transfection of MCF7
cells, ensuring nuclear origin andmaturation of themRNA,
although the nature and quantity of the transcript is less
controlled. These two complementary systems enable us
to examine the importance of both exact mRNA sequence
and ‘natural’ mRNA synthesis and biology. To determine
the requirement of eIF4A activity for the translation of
our reporters we measured the translational output of our
reporters with and without hippuristanol. The sensitivity
of our reporters to hippuristanol was used as a measure
of eIF4A dependency. Reporters with 5′UTRs from previ-
ously determined eIF4A-dependent mRNAs (9) were more
sensitive to hippuristanol than reporters with 5′UTRs from
mRNAs showing the opposite tendency (Supplementary
Figure S2), demonstrating that relative eIF4A dependency
is measurable in this system.
It is known that eIF4A is required to unwind classical sec-
ondary structures both at the very 5′ end of the mRNA dur-
ing ribosome recruitment, and further downstream during
scanning (3). To test whether eIF4A is required to unwind
G-quadruplexes during both steps, we placed the four po-
tential G-quadruplex forming sequences either at the very 5′
end of the message (Supplementary Figure S3A) or down-
stream of the -globin 5′UTR (Figure 1A), which is 50nt
long with moderate predicted secondary structure. Con-
trol reporters were scrambled sequences with the same nu-
cleotide composition but eliminated G-quadruplex forming
potential.
Three-layered but not two-layered G-quadruplexes fold in full
length mRNA reporters
To examine whether the sequences with G-quadruplex fold-
ing potential were folded in GQ2 and GQ3 reporters, we
first carried out reverse transcription stalling assays as in
(41). This technique relies on the fact that reverse transcrip-
tases stall at folded G-quadruplexes and that G-quadruplex
folding requires stabilization by a monovalent cation with
a strong preference of K+ over Li+ (41). Using full length
RNAwe were able to detect GQ3 sequences folding in vitro,
but we saw no evidence of GQ2 folding (Figure 1B). This
was evident from the extra band (marked by red asterisk)
observed for GQ3 with K+ but not Li+, one nucleotide be-
fore theG-quadruplex sequences, which is not seen forGQ2
or either controls.
Three-layered but not two-layered G-quadruplexes are in-
hibitory to translation and are more sensitive to eIF4A inhi-
bition than controls
in vitro translation assays showed that theGQ2 reporter was
translated at roughly the same levels as control and was no
more sensitive to hippuristanol, yet GQ3 was clearly trans-
lationally repressed and significantly more sensitive to hip-
puristanol than control (Figure 1C). This was mirrored in
the results from the cellular translation assays except that
the GQ2 reporter was surprisingly translated higher than
control, but its sensitivity to hippuristanol was not signif-
icantly different (Figure 1D). The increased sensitivity to
hippuristanol observed for GQ3 but not GQ2 was also ob-
served for the reporters with quadruplex sequences placed
close to the 5′ end of the message both in vitro (Supplemen-
tary Figure S3B) and in cells (Supplementary Figure S3C).
Taken together, these data show that sequences that have
the potential to fold into three-layered G-quadruplexes
readily fold in 5′UTRs of full length mRNA and this causes
translational repression with increased levels of eIF4A ac-
tivity required for both ribosome recruitment and scanning.
Meanwhile, two-layered G-quadruplexes were not seen to
fold in the reverse transcription stalling assay, showed no
increased sensitivity to hippuristanol compared to control,
and actually yielded more protein than control in cells. This
finding is in contrast with that of Wolfe et al. who found
that in KOPT-K1 cells a GQ2 reporter was significantly
more sensitive to the eIF4A inhibitor silvestrol compared
to control (13). To test if these differing findings were due
to the known different properties of different eIF4A in-
hibitors (45), we tested the sensitivity of our reporters to
silvestrol in cells. Interestingly, neither GQ2 nor GQ3 were
more sensitive to silvestrol than their controls (Figure 1E
and Supplementary Figure S4). This provides further evi-
dence that hippuristanol and silvestrol inhibit eIF4A activ-
ity through distinctmechanisms and suggests that the reper-
toire of mRNAs affected by such inhibition may be quite
distinct. Hippuristanol is known to lock eIF4A in a closed
conformation, unbound to RNA (40), thereby generating a
loss of eIF4A function, whereas inhibitors of the rocaglate
family, to which silvestrol belongs, act in a gain-of-function
manner by increasing eIF4A’s ability to ‘clamp’ upon poly-
purine rich sequences (46). Therefore, further experiments
were carried out only with hippuristanol, to isolate the he-
licase function of eIF4A.
Ablation of G-quadruplex formation with 7-deazaguanine
provides further evidence that three-layered but not two lay-
ered G-quadruplexes can fold and cause translational repres-
sion and eIF4A dependency
To ensure the reduced translational repression and in-
creased eIF4Adependency of theGQ3 reporter was directly
due to foldedG-quadruplexes and not additional properties
of the sequence, we made use of RNA transcribed with 7-
deazaguanine (c7G), which is identical to guanine except for
a carbon atom instead of nitrogen at position 7 (Figure 2A).
This N7 position is not involved in canonicalWatson–Crick
G:C base pairing (Figure 2B) but is essential for Hoog-
steen base pairing between guanines within G-tetrads (Fig-
ure 2C). Replacing guanine with 7-deazaguanine in the in
vitro transcription reaction therefore produces RNA capa-
ble of forming classical secondary structures but unable to
fold into G-quadruplexes (47).
We first demonstrated that RNA transcribed with 7-
deazaguanine cannot form G-quadruplexes, despite pos-
sessing the same nucleotide sequence, using reverse tran-
scription stalling assays (Figure 2D). Interestingly mRNA
transcribed with 7-deazaguanine was quite efficiently trans-
lated in vitro, showing that the N7 position is not vital to
mRNA decoding. Levels of translation were reduced com-
pared to normal RNA for the control reporters and GQ2,
but almost 2-fold higher for GQ3 (Figure 2E, left axis). This
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is further strong evidence that inhibitory G-quadruplex
structures form in GQ3 but not in GQ2. We next sought
to assess the impact that ablating G-quadruplexes had
on eIF4A dependency. Although all four constructs were
less sensitive to hippuristanol when transcribed with 7-
deazaguanine, and GQ3 is still the most sensitive to hip-
puristanol (Figure 2F), the relative levels of translation
from the 7-deazaguanine reporters compared to the nor-
mal RNA reporters was still much higher for GQ3 in the
presence of hippuristanol (Figure 2E, left axis). Further-
more, the alleviation of G-quadruplex mediated repression
for GQ3 is greater under conditions of eIF4A inhibition
(Figure 2E, left axis), providing direct evidence that eIF4A
activity is able to overcome the inhibitory effects of G-
quadruplex formation on translation when folded.
(GGA)4 sequences more readily fold into two-layered G-
quadruplexes compared with (GGC)4 sequences, yet are less
sensitive to eIF4A inhibition
These findings are in conflict with the in vivo biochem-
ical screens which specifically identified (GGC)4 but not
(GGGC)4 motifs as being enriched in eIF4A-dependent
5′UTRs. One explanation, which is supported by the reverse
transcription stalling assays, is that the (GGC)4 motifs are
not folding into G-quadruplexes in our synthetic reporters
due to competing Watson–Crick interactions. To increase
the likelihood for GQ2 folding we designed several more re-
porters in which theG-quadruplex sequences were placed in
a (CAA)n background (Figure 3A), tominimize the amount
of competing Watson–Crick interactions. As CAA repeats
have previously been shown to be single stranded (48), this
would also eliminate any secondary structures within the
rest of the 5′UTR, allowing us to more directly compare
the effects of the different quadruplex sequences on transla-
tion and eIF4A-dependency. We also wanted to investigate
whether the identity of the nucleotide within the loop of
the quadruplex is important for either quadruplex folding
and/or conferring eIF4A-dependency, as the (GGC)4 motif
previously identified suggests this needs to be a cytosine to
confer eIF4A-dependency. So that we could more directly
compare the effects on translation and eIF4A-dependency
between G-quadruplexes and hairpins we also designed
hairpin constructs matched in length.
Alternative predicted structures and the predicted min-
imum free energy of each 5′UTR were generated us-
ing RNAfold (43), either favouring or preventing G-
quadruplex formation (Supplementary Figure S5). Our
control (C2) is predicted to be almost completely single
stranded (Supplementary Figure S5A). GGCx1 is differ-
ent by just one nucleotide and has the potential to form
a two-layered G-quadruplex with C loops (Supplementary
Figure S5B), but if this does not fold, the 5′UTR would
also be almost entirely single stranded (Supplementary Fig-
ure S5C). GGAx1 is the same as GGCx1 except all the
C loops have been replaced by A (Supplementary Figure
S5D and E). GGCx2 and GGAx2 have the potential to
form two two-layeredG-quadruplexes (Supplementary Fig-
ure S5F and H). However, if these do not form, GGCx2
could form a modest hairpin structure with a predictedG
of -19.3kcal/mol (Supplementary Figure S5G), whereas
GGAx2 would be mostly single stranded with a predicted
G of –1.1 kcal/mol (Supplementary Figure S5I). GQHP2
is the same as GGCx2, except that the second (GGC)4 has
been replaced with a (CCG)4 motif. This means it could ei-
ther form one, two-layered G-quadruplex (Supplementary
Figure S5J) or a very stable hairpin structure of twelve G:C
base pairs (Supplementary Figure S5K). HP2 has the po-
tential to form the same hairpin structure as GQHP2, but
with the first G:C base pair switched, eliminating any clas-
sical G-quadruplex potential (Supplementary Figure S5L).
Reverse transcription stalling assays show modest K+
dependent stalling events with GGAx1 and more signif-
icant stalling with GGAx2 but none with either GGCx1
or GGCx2 (Figure 3B). This suggests that the cytosines in
the predicted loop positions are preventing G-quadruplex
folding, probably through competing Watson–Crick base
pairing. The greatly increased stalling with GGAx2 com-
pared to GGAx1 most likely reflects the fact that, although
there are only two non-overlapping G-quadruplex-forming
sequences in GGAx2, there are seventy potential overlap-
ping G-quadruplex-forming sequences. These overlapping
sequences could form G-quadruplexes from non-adjacent
G-doublets, resulting in longer internal loops. This is sup-
ported by the presence of the higher band which represents
stalling at one of these overlapping G-quadruplexes. The
stalling events observed with GQHP2 and HP2 represent
classical hairpin structures as they are not dependent onK+.
The results obtained from the translation assays were dif-
ferent when carried out in vitro (Figure 3C) and in cells
(Figure 3D). in vitro, GQHP2 and HP2 were translation-
ally repressed and were the most sensitive to hippuristanol
compared with all the two-layered G-quadruplex reporter
constructs and control. This suggests that hairpins are more
inhibitory to translation than two-layered G-quadruplexes
due to a higher dependence on eIF4A activity. In support of
this, GGCx2 was significantly more sensitive to hippuris-
tanol than control but GGAx2 was not (Figure 3C), de-
spite our RT stalling assays showing that GGAx2 is more
likely to fold into a quadruplex than GGCx2 (Figure 3B),
which likely adopts a hairpin structure (Supplementary Fig-
ure S5G). Interestingly, GGAx1 and GGAx2, which both
form folded G-quadruplexes, were translated at higher lev-
els than C2, GGCx1 and GGCx2 which do not. This sug-
gests that folded two-layered G-quadruplexes are less in-
hibitory to translation than even modest secondary struc-
tures.
In cells, GQHP2 and HP2 were again translationally re-
pressed but only GQHP2 was more sensitive to hippuris-
tanol than control. Also, GGCx2 and GGAx2 were trans-
lated at higher levels than C2 but were not more sensitive
to hippuristanol. The difference between results obtained in
vitro and in cells is likely explained by the different methods
of transcription for these mRNA reporters. Whereas the in
vitro assays use in vitro transcribed RNA, where we can be
sure that transcription starts at the guanine of the GAA-
CAA, just upstream of the quadruplex sequence, transcrip-
tion of the reporters in cells is under the control of the SV40
promoter which introduces upstream sequences. There are
three possible transcription start sites for mRNAs derived
from the SV40 promoter (49) and the sequences from all
three sites are predicted to fold into stable secondary struc-
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Figure 3. (GGA)4 but not (GGC)4 sequences fold into G-quadruplexes but (GGC)4 sequences confer more eIF4A dependency for translation. (A) Dia-
grammatic representation of the seven reporter constructs used in this figure. Guanines which can form G-quadruplexes are in bold and blue. Nucleotides
in red correspond to the K+ dependent stalling events marked by red asterisks in (B). Green nucleotides mark the stems of the hairpins in the two hairpin
constructs. Predicted G values are shown with and without quadruplex folding using RNAfold (43). (B) Reverse transcription stalling assays using full
length RNA shows K+ dependent stalling (red asterisk) one nucleotide before the G-quadruplex sequences (blue lines) in GGAx1 and GGAx2. G-ladder
wasmadewithGGCx2RNAwith Li+ and the addition of ddCTP. (C) in vitro translation assays with andwithout 4Mhippuristanol. Fluc was normalized
to HCV-Rluc (right axis) and then normalized to 0 M hippuristanol (left axis). (D) Cellular translation assays with and without 200 nM hippuristanol.
Fluc was normalized to Rluc (right axis) and then normalized to 0 nM hippuristanol (left axis). n= 3 biological replicates. Error bars represent SEM. ns=
not significant, **P< 0.01, ***P< 0.001 and ****P< 0.0001 using a repeated measures one-way ANOVA comparing each value with C2, using Dunnet’s
multiple comparisons test. Individual Fluc and Rluc measurements are presented in Supplementary Figure S9.
tures (Supplementary Figure S6), thereby likely confound-
ing the effects of our relatively small inserted elements,
as well as potentially directly structurally interacting with
them.
Pyridostatin stabilizes two-layered G-quadruplexes, which is
inhibitory to translation
Overall, these findings suggest that within natural cellular
5′UTRs, two-layered G-quadruplexes are very unlikely to
fold unless they are stabilized in some manner, for example
by an RNA or G-quadruplex specific binding protein, or
perhaps due to specific sequence context. We therefore de-
cided to investigate the effect of quadruplex stabilization on
translation and eIF4A-dependency, using the commercially
available G-quadruplex stabilizing ligand pyridostatin (50).
In the presence of pyridostatin, we now observe addi-
tional reverse transcription stalling events one nucleotide
before the G-quadruplex sequences in GQ2, GGCx1,
GGCx2 and GQHP2 (Figure 4A and B). We also see in-
creased stalling in GGAx1 and GGAx2 (Figure 4B). Cru-
cially, this stalling is dependent on the N7 moiety, as GQ2
RNA transcribed with 7-deazaguanine (c7G) failed to stall
the reverse transcriptase at these positions (Figure 4A),
which demonstrates that the additional stalling bands are
directly caused by quadruplex stabilization. Because, in
the presence of K+, three-layered G-quadruplexes are al-
ready folded and cause near-complete reverse transcriptase
stalling, we needed to test the ability of pyridostatin to fur-
ther stabilize these structures in the presence of Li+. Under
these conditions, pyridostatin does indeed stabilize three-
layered G-quadruplexes, which is also N7 dependent (Fig-
ure 4A).
The addition of pyridostatin to the in vitro translation as-
says inhibited translation of all reporters, but the levels of
inhibition were significantly greater for reporters contain-
ing potential G-quadruplex forming sequences than con-
trols (Figure 4C and D). GGAx2 was more sensitive to
pyridostatin than GGCx2, further suggesting that (GGA)4
sequences more easily fold into G-quadruplexes compared
with (GGC)4 sequences. Reporters with two potential non-
overlapping quadruplex sequences were also more sensi-
tive to pyridostatin than reporters with just one potential
quadruplex sequence.Despite stabilizingG-quadruplex for-
mation in GQHP2 in the reverse transcription stalling assay
(Figure 4B), pyridostatin inhibited translation of GQHP2
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Figure 4. Pyridostatin stabilizes both two and three-layered G-quadruplexes, resulting in translational inhibition. (A and B) Reverse transcription stalling
assays using full length RNA with and without pyridostatin. Stalling events (red asterisks) one nucleotide before the G-quadruplex sequences (blue lines)
in the presence of pyridostatin indicates that this drug is able to stabilize these structures, which is not seen with RNA transcribed with 7-deazaguanine
(c7G). G-ladders are as used in Figures 1B and 3B. (C and D) in vitro translation assays with and without 5 M pyridostatin. Fluc was normalized to
HCV-Rluc and then to 0 M pyridostatin. (E and F) Cellular translation assays with and without 5 M pyridostatin. Fluc was normalized to Rluc and
then to 0 M pyridostatin. n = 3 biological replicates. Error bars represent SEM. ns = not significant, *P < 0.05, **P < 0.01 and ****P < 0.0001 using a
repeatedmeasures one-way ANOVAwith Sidak’s multiple comparisons test for (C and E) andDunnet’s multiple comparisons test for (D and F) comparing
each reporter to C2 only. Individual Fluc and Rluc measurements are presented in Supplementary Figures S10 and S11.
less than C2 and to the same extent as HP2 which has no
G-quadruplex potential, suggesting the stable hairpin struc-
ture in GQHP2 is able to outcompete G-quadruplex forma-
tion in the in vitro translation assay, even in the presence of
pyridostatin.
The pyridostatin-induced reduction in translation from
our controls suggests the possibility of non-canonical
quadruplex formation, as has been shown previously (35).
This could explain the faint increase in band intensity seen
for C2 with pyridostatin (Figure 4B). The increased sensi-
tivity to pyridostatin of C2 compared to GQHP2 and HP2
likely reflects the lack of any competing Watson–Crick in-
teractions for C2, therefore increasing the chances of non-
canonical quadruplex formation. The results obtained in
cells matched those seen in vitro, except that reporters with
two potential G-quadruplex sequences were no more sen-
sitive to pyridostatin than reporters with just one potential
G-quadruplex sequence (Figure 4E and F).
In summary, we find that in the presence of a G-
quadruplex stabilizing ligand, two-layered G-quadruplexes
do fold and do impede translation. How does this stabiliza-
tion of G-quadruplexes influence eIF4A dependency? To
investigate this, we carried out translation assays with and
without pyridostatin, with andwithout hippuristanol for all
our constructs both in vitro (Figure 5A and B) and in cells
(Figure 5C and D).
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Figure 5. Reporters are more dependent on eIF4A activity when folded into hairpins than G-quadruplexes. (A and B) in vitro translation assays with and
without 4 M hippuristanol, with and without 5 M pyridostatin. Fluc was normalized to HCV-Rluc and then to 0 M hippuristanol with or without
pyridostatin. (C and D) Cellular translation assays with and without 200 nM hippuristanol, with and without 5 M pyridostatin. Fluc was normalized
to Rluc and then to 0 nM hippuristanol with or without pyridostatin. n = 3 biological replicates. Error bars represent SEM. ns = not significant, *P <
0.05, **P < 0.01, ***P < 0.001 and ****P < 0.0001 using a repeated measures two-way ANOVA with Sidak’s multiple comparison test. Individual Fluc
and Rluc measurements are presented in Supplementary Figures S12 and S13. (E) Model summarizing our observations that classical Watson–Crick
secondary structures confer increased dependency on eIF4A activity than G-quadruplexes. Under normal conditions, (GGC)4 motifs prefer to fold into
classical secondary structures rather than G-quadruplexes. mRNAs that possess these secondary structures within their 5′UTRs are more sensitive to
eIF4A inhibition than if these sequences were folded into G-quadruplexes. This is supported by our observation that when the structural equilibrium is
shifted in favour of G-quadruplexes with pyridostatin, the requirement for eIF4A activity is diminished.
(GGC)4 sequences are more sensitive to eIF4A inhibition
when folded into classical secondary structures than into G-
quadruplexes
Strikingly, pyridostatin reduced the sensitivity to hippuris-
tanol for GQ2 (Figure 5A) and GGCx2 (Figure 5B) but
none of the other constructs in vitro. Therefore, the effect
is restricted to those constructs that have the potential to
fold into G-quadruplexes but only do so when stabilized
by pyridostatin, such that when the equilibrium is shifted
from classical Watson–Crick secondary structures towards
G-quadruplexes the sensitivity to hippuristanol decreases
(Figure 5E). This supports the hypothesis that canoni-
cal secondary structures confer increased dependency for
eIF4A compared to G-quadruplexes, as the same sequence
is more dependent on eIF4A when folded into a hairpin
structure than when folded into a G-quadruplex. We can
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rule out that this effect is simply due to pyridostatin bind-
ing the quadruplex which could disrupt eIF4A’s ability to
unwind the quadruplex, as the sensitivity to hippuristanol
for GGAx2 is not affected by pyridostatin (Figure 5B).
In cells, we see reduced sensitivity to hippuristanol with
pyridostatin for all our reporters with potential quadruplex
sequences (Figure 5C and D). As described earlier these
reporters will have extra 5′ sequence when transcribed in
cells compared to in vitro, which could either interfere with
quadruplex folding through competing Watson–Crick in-
teractions or could fold into stable secondary structures
which could dilute the effect that a downstream folded
quadruplex has on translation. This data is therefore consis-
tent with our hypothesis that the reduction in hippuristanol
sensitivity/eIF4A dependency is due to a shift in struc-
tural equilibrium away from Watson–Crick structures and
towards G-quadruplexes as these constructs now have the
additional potential to fold into classical secondary struc-
tures in cells. In agreement with this, we saw a greater al-
leviation of hippuristanol sensitivity with pyridostatin for
theGGA constructs compared to theGGC constructs (Fig-
ure 5D), due to these sequences more easily folding into G-
quadruplexes. The fact that we see a strong alleviation in
hippuristanol sensitivity with pyridostatin for GQ3 in cells
(Figure 5C), but not in vitro (Figure 5A), suggests that the
secondary structures introduced upstream by DNA trans-
fection are more dependent on eIF4A activity for their un-
winding than the three-layered G-quadruplexes.
DISCUSSION
This study aimed to dissect the role that G-quadruplex
structures play in regulating translational control. in vivo
biochemical screens from our lab (9) and others (13,16),
had previously identified (GGC)4 sequences as being en-
riched in the 5′UTRs of eIF4A-dependent mRNAs. It had
previously been shown that these sequences can fold into
G-quadruplexes using short oligonucleotides by biophysi-
cal techniques. It was expected that these sequences would
also fold into G-quadruplexes in full-length mRNAs, and
it is widely understood that this confers increased depen-
dency on eIF4A for translation. However, not only do we
find that (GGC)4 sequences fail to fold intoG-quadruplexes
in reporter mRNAs, but the much less common, and gen-
erally non-enriched, (GGA)4 sequences do fold into G-
quadruplexes. Furthermore, (GGC)4 elements are more de-
pendent on eIF4A than (GGA)4 elements, showing that the
classical secondary structures formed by (GGC)4 sequences
dictate greater dependence upon eIF4A activity than the
two-layered G-quadruplexes formed by (GGA)4. In sup-
port of this, when we shifted the structural equilibrium of
reporters from Watson–Crick secondary structures to G-
quadruplexes, using a G-quadruplex stabilizing ligand, we
observed a decrease in hippuristanol sensitivity/eIF4A de-
pendency (Figure 5E).
Our data therefore suggest that the enrichment of
(GGC)4 motifs in the 5′UTRs of eIF4A-dependentmRNAs
is a consequence of their ability to form classical Watson–
Crick secondary structures rather than G-quadruplexes. It
is possible that there is something innate about (GGC)4-
formed classical structures which demands higher levels of
eIF4A activity compared with similar GC-rich sequences.
Alternatively, given that (GGC)4 sequences are the most
common trinucleotide repeat within 5′UTRs (51), the en-
richment of (GGC)4 motifs may be a passenger phe-
nomenon of general classical structure formation, given
that we already know the requirement of eIF4A for trans-
lation is strongly associated with the degree of classical sec-
ondary structure within the 5′UTR (9,13,16,52).
Although we designed a wide range of reporters, we can-
not rule out the possibility that the sequence/structural con-
text of the G-quadruplex is key, and our system did not re-
capitulate this. Alternatively, a unique ability to switch be-
tween classical and G-quadruplex conformations innate to
the (GGC)4 motif may be biologically important in some
way that we cannot as yet discern. Although three-layered
G-quadruplexes do fold and strongly inhibit translation,
and can be overcome by eIF4A activity, our data over-
whelmingly support a model in which classical inhibitory
Watson–Crick secondary structures are more susceptible to
eIF4A inhibition. This explains why we see an enrichment
of (GGC)4 elements but not (GGA)4 or (GGU)4, or se-
quences that have the potential to fold into three-layered
G-quadruplexes, enriched in the 5′UTRs of eIF4A depen-
dent mRNAs.
Whatever the precisemechanisms at play, the central find-
ing is that the ability to regulate mRNA translation by the
alteration of eIF4A activity appears to be much more de-
termined by classical Watson–Crick secondary structures
rather than by G-quadruplexes. This has significant impli-
cations for the elucidation of this key axis in the control of
both global and message-specific gene expression, and by
extension the therapeutic targeting of this mechanism. Fur-
thermore, even though (GGC)4 elements rarely fold into
G-quadruplexes in full length mRNAs, our findings that
quadruplex folding can be stabilized for these sequences in
vivo, and that this alleviates the sensitivity of these mR-
NAs to eIF4A inhibition, have interesting clinical implica-
tions for targeting translation via direct stabilization of G-
quadruplexes.
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Supplementary Data are available at NAR Online.
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